Gain Therapeutics, Inc. (GANX) Stock Price History
Historical prices from 2021 to 2026
Loading 10-year price history...
GANX Historical Performance
Short-Term Returns
GANX Stock Price Trajectory (2021–2026)
As of May 8, 2026, Gain Therapeutics, Inc. (GANX) trades at $1.87, representing a -4.1% return over the past year. The stock has delivered a -82.2% total return over five years (-29.2% CAGR), reflecting challenging market conditions.
The stock reached its all-time high of $17.93 on April 12, 2021. From this peak, GANX has corrected -89.6%, currently trading 14% below its 200-day moving average, suggesting potential weakness.
When compared to Healthcare sector peers PRAX (+775.0% 1Y), ACMR (+195.6% 1Y), and RARE (-21.8% 1Y), GANX has underperformed the peer group average. Compare GANX vs PRAX →
GANX Historical Price Data (2025–2026)
Showing 30 of 1,292 recordsLoading full history…
| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-05-07 | 1.92 | 1.92 | 1.81 | 1.87 | 343K | -2.09% |
| 2026-05-06 | 1.88 | 1.93 | 1.86 | 1.91 | 413K | +2.14% |
| 2026-05-05 | 1.90 | 1.91 | 1.87 | 1.87 | 56K | -1.58% |
| 2026-05-04 | 1.89 | 1.95 | 1.87 | 1.90 | 560K | +1.06% |
| 2026-05-01 | 1.84 | 1.93 | 1.83 | 1.88 | 423K | -0.53% |
| 2026-04-30 | 1.79 | 1.90 | 1.78 | 1.89 | 471K | +7.39% |
| 2026-04-29 | 1.86 | 1.86 | 1.71 | 1.76 | 914K | -4.86% |
| 2026-04-28 | 1.92 | 1.97 | 1.85 | 1.85 | 448K | -5.13% |
| 2026-04-27 | 1.99 | 2.02 | 1.93 | 1.95 | 491K | -1.02% |
| 2026-04-24 | 1.91 | 2.05 | 1.88 | 1.97 | 663K | +4.23% |
| 2026-04-23 | 2.00 | 2.04 | 1.89 | 1.89 | 572K | -7.35% |
| 2026-04-22 | 2.12 | 2.14 | 2.02 | 2.04 | 338K | -2.39% |
| 2026-04-21 | 2.12 | 2.19 | 2.07 | 2.09 | 454K | -1.42% |
| 2026-04-20 | 2.14 | 2.18 | 2.09 | 2.12 | 523K | -0.47% |
| 2026-04-17 | 2.10 | 2.20 | 2.06 | 2.13 | 680K | +3.90% |
| 2026-04-16 | 2.14 | 2.15 | 2.05 | 2.05 | 421K | -4.21% |
| 2026-04-15 | 1.93 | 2.15 | 1.88 | 2.14 | 778K | +13.23% |
| 2026-04-14 | 1.89 | 2.00 | 1.85 | 1.89 | 633K | +1.07% |
| 2026-04-13 | 1.76 | 1.90 | 1.76 | 1.87 | 685K | +3.89% |
| 2026-04-10 | 1.84 | 1.84 | 1.78 | 1.80 | 405K | -2.17% |
| 2026-04-09 | 1.80 | 1.88 | 1.78 | 1.84 | 331K | +2.22% |
| 2026-04-08 | 1.93 | 1.94 | 1.77 | 1.80 | 609K | -2.70% |
| 2026-04-07 | 1.83 | 1.85 | 1.72 | 1.85 | 670K | -0.54% |
| 2026-04-06 | 1.86 | 1.95 | 1.82 | 1.86 | 518K | +0.54% |
| 2026-04-02 | 1.87 | 1.96 | 1.83 | 1.85 | 519K | -4.64% |
| 2026-04-01 | 1.95 | 2.04 | 1.89 | 1.94 | 563K | 0.00% |
| 2026-03-31 | 1.82 | 1.96 | 1.82 | 1.94 | 365K | +7.78% |
| 2026-03-30 | 1.84 | 1.84 | 1.73 | 1.80 | 475K | -1.64% |
| 2026-03-27 | 1.90 | 1.94 | 1.75 | 1.83 | 886K | -3.17% |
| 2026-03-26 | 1.95 | 2.07 | 1.88 | 1.89 | 455K | -3.57% |
See GANX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs GANX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare GANX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonGANX — Frequently Asked Questions
Quick answers to the most common questions about buying GANX stock.
How has GANX stock performed recently?
GANX declined -4.1% over the past year, below its 5-year annualized CAGR of -29.2%. The stock trades below its 200-day moving average, reflecting the downtrend.
What is GANX's all-time high price?
Gain Therapeutics, Inc. reached $17.93 on 2021-04-12. The 52-week high is $4.34. Current 1-year return of -4.1% places the stock further from historical peaks.
Where can I download GANX historical price data?
This page provides GANX daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2021-2026, downloadable in CSV format.